Trevena Inc (TRVN)
0.402
+0.01
(+2.29%)
USD |
NASDAQ |
Apr 17, 16:00
0.4173
+0.02
(+3.81%)
Pre-Market: 08:51
Trevena Cash and Short Term Investments (Quarterly): 32.98M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.98M |
| September 30, 2023 | 34.95M |
| June 30, 2023 | 28.10M |
| March 31, 2023 | 27.44M |
| December 31, 2022 | 38.32M |
| September 30, 2022 | 40.39M |
| June 30, 2022 | 49.52M |
| March 31, 2022 | 48.66M |
| December 31, 2021 | 66.92M |
| September 30, 2021 | 78.65M |
| June 30, 2021 | 90.95M |
| March 31, 2021 | 97.72M |
| December 31, 2020 | 109.40M |
| September 30, 2020 | 112.68M |
| June 30, 2020 | 54.80M |
| March 31, 2020 | 28.09M |
| December 31, 2019 | 35.80M |
| September 30, 2019 | 44.72M |
| June 30, 2019 | 53.97M |
| March 31, 2019 | 60.06M |
| December 31, 2018 | 61.48M |
| September 30, 2018 | 70.04M |
| Date | Value |
|---|---|
| June 30, 2018 | 63.50M |
| March 31, 2018 | 61.59M |
| December 31, 2017 | 66.10M |
| September 30, 2017 | 76.57M |
| June 30, 2017 | 84.20M |
| March 31, 2017 | 97.91M |
| December 31, 2016 | 110.60M |
| September 30, 2016 | 119.61M |
| June 30, 2016 | 144.51M |
| March 31, 2016 | 163.47M |
| December 31, 2015 | 172.64M |
| September 30, 2015 | 168.97M |
| June 30, 2015 | 106.38M |
| March 31, 2015 | 100.77M |
| December 31, 2014 | 106.90M |
| September 30, 2014 | 72.22M |
| June 30, 2014 | 81.62M |
| March 31, 2014 | 91.34M |
| December 31, 2013 | 37.97M |
| September 30, 2013 | 47.98M |
| June 30, 2013 | 54.77M |
| December 31, 2012 | 6.739M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
27.44M
Minimum
Mar 2023
112.68M
Maximum
Sep 2020
56.53M
Average
48.66M
Median
Mar 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 23.18M |
| Ampio Pharmaceuticals Inc | 4.089M |